Piperonyl butoxide 0.035 MG/MG / pyrethrins 0.003 MG/MG Topical Gel — RxCUI 2058503
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Pyrethrin and Piperonyl Butoxide Topical: what it is, how it’s used, side effects, and interactions.
- It treats head lice, pubic (crab) lice, and body lice. You apply it to the hair or the affected skin area.
- What is Pyrethrin and Piperonyl Butoxide Topical used for?
- Leave it on for 10 minutes, but no longer. Then wash the area well with warm water and soap or shampoo. Apply it to dry hair first.
- Yes. A second treatment is needed in 7 to 10 days to kill any newly hatched lice. Check daily for lice or nits you missed. If the infestation continues, see a doctor for other trea...
🕸️ Concept Web — How Piperonyl butoxide 0.035 MG/MG / pyrethrins 0.00... Connects
RxCUI 2058503 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 3
The active substance itself — no strength, form, or brand attached yet.
-
Piperonyl butoxide
8345IN -
Pyrethrins
8991IN -
Piperonyl butoxide / pyrethrins
91299MIN
-
Piperonyl butoxide
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Vanalice
2058504BN
-
Vanalice
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Piperonyl butoxide / pyrethrins Topical Gel
378027SCDF -
Piperonyl butoxide / pyrethrins Topical Product
1159281SCDG -
Piperonyl butoxide / pyrethrins Topical Gel [Vanalice]
2058506SBDF -
Vanalice Topical Product
2058507SBDG -
Topical Gel
346286DF -
Topical Product
1151122DFG
-
Piperonyl butoxide / pyrethrins Topical Gel
-
Clinical & branded drugs 4
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Piperonyl butoxide 0.035 MG/MG
2058502SCDC -
Pyrethrins 0.003 MG/MG
340040SCDC -
Piperonyl butoxide 0.035 MG/MG / pyrethrins 0.003 MG/MG Topical Gel [Vanalice]
2058508SBD -
Piperonyl butoxide 0.035 MG/MG / pyrethrins 0.003 MG/MG [Vanalice]
2058505SBDC
-
Piperonyl butoxide 0.035 MG/MG
🔀 Generic ⇄ Brand Crosswalk
Generic (Clinical) Concepts
-
Piperonyl butoxide 0.035 MG/MG
SCDC · 2058502 -
Pyrethrins 0.003 MG/MG
SCDC · 340040 -
Piperonyl butoxide / pyrethrins Topical Gel
SCDF · 378027 -
Piperonyl butoxide / pyrethrins Topical Product
SCDG · 1159281
Brand-Name Concepts
-
Piperonyl butoxide 0.035 MG/MG / pyrethrins 0.003 MG/MG Topical Gel [Vanalice]
SBD · 2058508 -
Piperonyl butoxide 0.035 MG/MG / pyrethrins 0.003 MG/MG [Vanalice]
SBDC · 2058505 -
Piperonyl butoxide / pyrethrins Topical Gel [Vanalice]
SBDF · 2058506 -
Vanalice Topical Product
SBDG · 2058507 -
Vanalice
BN · 2058504
📦 FDA Products & Package NDCs
1 product · 1 package NDC
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 58809-0650-08 | 237 mL in 1 BOTTLE (58809-650-08) | Vanalice | GM Pharmaceuticals, INC | 2018-08-05 |
💲 Pricing (NADAC)
🗃️ Sources & Limits
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.